Related Experiment Video
Updated: Sep 15, 2025
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
High expression of DGKA indicates poor overall survival of nasopharyngeal carcinoma
Hao Chen1,2, Runduan Lin1,3, Qi Yuan1,2
1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer,Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
Background:
Nasopharyngeal carcinoma (NPC) is a malignant tumor with strong tendency of metastasis and recurrence. Therefore, prognostic indicators for NPC are urgently needed. DGKA is overexpressed in many cancers. However, the role of DGKA in NPC remains unclear. The aim of this study is to investigate the expression patterns and prognostic value of DGKA in NPC.
Methods:
The mRNA expression of DGKA was analyzed from the dataset of The Cancer Genome Atlas (TCGA). Immunohistochemistry was performed to detect the expression of DGKA in 124 paraffin-embedded samples. Survival analysis was conducted according to the Kaplan-Meier method. Univariate and multivariate Cox regression analyses were used to identify the independent prognostic factors.
Results:
We found the mRNA expression of DGKA was significantly higher in tumor tissues than in adjacent tissues in TCGA datasets. Besides, the comparison of the different clinicopathological features of NPC between high and low DGKA expression groups revealed that high DGKA expression was related to the survival status (p = 0.008). Statistical analysis indicates that high expression of DGKA is associated with poor prognosis in NPC. A monogram model was successfully established and demonstrated favorable predictive performance. Bioinformatics analysis showed that DGKA was associated with the activation of oncogenic signaling pathways and the reduction of anti-tumor CD8 + T cell infiltration.
Conclusion:
High expression of DGKA is associated with poor overall survival of NPC patients. DGKA is expected to be a potential biomarker and therapeutic target for NPC.
